Atlas Trials

Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa

Clinical trial NCT02014376 · COMPLETED

Trial details

NCT number
NCT02014376
Sponsor
Scioderm, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Epidermolysis Bullosa
Start date
2014-01-06
Primary completion
2014-06-24
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.